JPRN-jRCT1080222828
Unknown
未知
A multicenter, longitudinal, non-drug study to assess the suitability of neurocognitive tests and functioning scales for the measurement of cognitive and functioning changes in Japanese individuals with Down syndrome aged 6-30.
ConditionsDown Syndrome
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Down Syndrome
- Sponsor
- Chugai Pharmaceutical Co., Ltd.
- Enrollment
- 40
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\*Subjects with diagnosis of Down Syndrome.Subjects may have standard trisomy 21, Robertsonian translocation, isochromosome21,Down syndrome with reciprocal translocation or mosaicism.
- •\*Availability of parent or other reliable caregiver who agrees to accompany the subject to clinic visits, provide information about the subject's behavior and symptoms.
- •\*Down Syndrome subjects meeting clinical diagnostic criteria for generalized anxiety disorders, major depressive disorders, autism spectrum disorder, attention deficit and hyperactivity disorder, can participate to the study provided they are on stable medication for at least 8 weeks prior to screening.
Exclusion Criteria
- •Individuals who may not be able to comply with the protocol or perform the outcome measures due to significant hearing or visual impairment or other issues judged relevant by the investigators.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
A study investigating the effectiveness, safety and quality of life in participants with age related visual impairment (macular degeneration) who have switched to faricimab, under real world conditions in Germanyeovascular age related macular degeneration (nAMD)Eye DiseasesISRCTN27514808Roche Pharma (Roche Germany)620
Completed
Not Applicable
A Prospective, Non-randomized, Multicenter Study of the Efficacy of Adhesion Barriers in Laparoscopic Surgery for Colorectal Cancer in JapaColorectal CancerJPRN-UMIN000035144Department of Clinical Oncology, Kawasaki Medical School452
Completed
Not Applicable
A Non-interventional, multicentre study to see prevalence of BRCA1 and BRCA2 mutation among ovarian, primary peritoneal and fallopian tube cancer patients in IndiaCTRI/2018/08/015338AstraZeneca Pharma India Ltd
Completed
Not Applicable
on-interventional study to compare metabolic parameters(including lipid tests, insulin sensitivity, liver fat, visceral/ subcutaneous fat)between diabetic and healthy subjectsHealth Condition 1: null- Diabetic patientsCTRI/2011/07/001904Torrent Pharmaceuticals Limited150
Completed
Not Applicable
Study to determine the local prevalence in Indian patients in Prostate cancerCTRI/2021/12/038578AstraZeneca Pharma India Ltd211